Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

321
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
321

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Prognostic Reclassification and Survival Outcomes in Intermediate-Risk and Poor-Risk Nonseminomatous Germ Cell Tumors: Single-Institution Experience From Western India.

JCO global oncology·2026
Same author

Microenvironmental Cues That Regulate Cancer Cell Dormancy in Estrogen-Receptor Positive and Triple-Negative Breast Cancer Cell Lines.

Cancer medicine·2026
Same author

Integrating Metronomic Therapy With Standard Chemotherapy in Advanced Unresectable Head and Neck Cancer: A Randomized Trial Addressing Global Cancer Care Equity (METRO PLUS).

JCO global oncology·2026
Same author

Hypoxia-reoxygenation cycle leads to context dependent phenotypic effects in breast cancer cell lines.

Molecular biology reports·2026
Same author

Persistent Fluorodeoxyglucose Uptake on Post-Definitive Radiotherapy PET/CT Evaluation Predicts Poor Survival in Pediatric Metastatic Ewing Sarcoma: A Single-Center Cohort Study.

Cancer medicine·2026
Same author

The Practice of Cytopathology in India: Insights From a 2025 Nationwide Survey.

Diagnostic cytopathology·2026

Related Experiment Video

Updated: May 29, 2025

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
08:52

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Published on: June 13, 2018

8.8K

Prognostic Modeling for Bone Sarcomas Based on a Large Prospective Cohort From a Tertiary Care Cancer Center in

Jyoti Bajpai1, Laboni Sarkar1, Sushmita Rath1

  • 1Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Mumbai, India.

JCO Global Oncology
|February 6, 2025
PubMed
Summary

This study developed a risk-scoring system for adolescents and young adults with bone sarcomas like osteosarcoma and Ewing sarcoma. The models identify key factors to predict outcomes in these young cancer patients.

More Related Videos

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone
06:53

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

Published on: September 9, 2020

2.7K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

204

Related Experiment Videos

Last Updated: May 29, 2025

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
08:52

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Published on: June 13, 2018

8.8K
Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone
06:53

Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone

Published on: September 9, 2020

2.7K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

204

Area of Science:

  • Oncology
  • Pediatric Oncology
  • Cancer Research

Background:

  • Outcomes for adolescents and young adults (AYA) with bone sarcomas are influenced by factors like prior treatment and adherence.
  • Developing accurate prognostic tools is crucial for tailoring treatment strategies.

Purpose of the Study:

  • To develop and validate a risk-scoring system for AYA with osteosarcoma (OGS) and Ewing sarcoma (ES).
  • To identify key prognostic factors affecting outcomes in AYA bone sarcoma patients in India.

Main Methods:

  • Prospective analysis of AYA OGS and ES cases treated between 2011-2021 and 2013-2018.
  • Development of a multivariable model to assign weighted scores to prognostic variables.
  • Validation of the risk groups using derivation, validation, and whole cohorts.

Main Results:

  • For nonmetastatic OGS, factors included protocol completion failure, previous treatment, necrosis, joint involvement, and alkaline phosphatase levels.
  • For ES, significant factors were protocol completion failure, previous treatment, necrosis, and tumor size.
  • For metastatic OGS and ES, factors like protocol completion failure, metastasis characteristics, and tumor burden were significant.

Conclusions:

  • Simple and effective prognostic models were developed for AYA with bone sarcomas.
  • These models have potential relevance for improving cancer care in low- and middle-income countries.